Drug development is a long process because a potential new drug must be identified and then evaluated in preclinical and clinical studies. The discovery of a potential new drug can occur several different ways.3 Researchers may identify a new drug by testing numerous compounds in a laboratory panel to assess for any beneficial effects, such as stopping cancer cell growth or killing cancer cells.new understanding of a cancer type can lead to rational drug design, in which a compound is developed to target a specific disease process. Sometimes, existing drugs are found to have a beneficial effect against a different cancer type. Finally, new technologies and/or formulation designs can change how drugs reach cancer cells within the body, thus leading to the ability to develop a compound that may not have been possible previously. This initial process is referred to as target and lead identification, validation, and optimization.
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Review Article: Cancer Science & Therapy
Review Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Cancer Science & Therapy received 5332 citations as per Google Scholar report